Marley Drug
Performance
Help| Portfolio Return | 0.00% | 0.00% | 0.00% |
| Comparable Target-Date Fund [why this comparison?] |
0.00% Target-Date 2020 |
0.00% Target-Date 2030 |
0.00% Target-Date 2050 |
| Value-added by Kivalia ($100k starting amount) |
0.0 (0.0%) | 0.0 (0.0%) | 0.0 (0.0%) |
Current Recommendations
(as of 9/30/2020)Help| NAME | TICKER | CONSERVATIVE | MODERATE | AGGRESSIVE |
|---|---|---|---|---|
| American Century Investments Ginnie Mae Fund Class R | AGMWX | 36% | 17% | - |
| Goldman Sachs High Yield Fund Class R | GSHRX | 14% | 7% | - |
| MM S&P 500 Index Fund Class R3 | MMINX | 41% | 59% | 71% |
| JPMorgan Small Cap Value Fund Class R2 | JSVZX | 9% | 10% | 11% |
| Delaware Emerging Markets Fund Class R | DEMRX | - | 7% | 7% |
| MFS Blended Research Core Equity Fund Class R2 | MUESX | - | - | 11% |
| Total Portfolio | 100% | 100% | 100% |